Colorectal Cancer Clinical Trials in Cincinnati, OH

Colorectal Cancer Clinical Trials in Cincinnati, OH

View the best 10 colorectal cancer medical studies in Cincinnati, Ohio. Access promising new therapies by applying to a Cincinnati-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in Cincinnati, Ohio

Here are the top 10 medical studies for colorectal cancer in Cincinnati, Ohio

Image of UCLA Medical Center in Los Angeles, United States.

IDE196

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2
This trial is testing the safety and effectiveness of a new drug, IDE196, for patients with solid tumors that have a specific gene mutation. The trial has three parts. First, they will test different doses of the drug to see what is safe and what the side effects are. Second, they will test the drug combination with binimetinib to see if it is effective and has any new side effects. Third, they will test the drug combination with crizotinib to see if it is effective and has any new side effects.
Image of Yale University in New Haven, United States.

VV1 +1 More

Virus Therapy

Recruiting1 awardPhase 2
This trial is testing a new cancer drug, VV1, to see if it is safe and effective when used with cemiplimab to treat patients with NSCLC or melanoma.
Image of Cedars-Sinai Medical Center in Los Angeles, United States.

RGX-202-01 +1 More

Small Molecule Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug, RGX-202-01, to see if it can shrink tumors in people with gastrointestinal cancer. The study will test different doses of the drug to see what is safe and effective. The study will also test the drug in combination with other drugs that are commonly used to treat gastrointestinal cancer.
Image of Children's Hospital of Alabama in Birmingham, United States.

Tegavivint

Beta-catenin/TBL1 Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug to see if it can stop the growth of cancer cells.
Image of CTCA at Western Regional Medical Center in Goodyear, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.
Image of St. Bernards Medical Center in Jonesboro, United States.

Onvansertib

Protein Kinase Inhibitor

Recruiting1 awardPhase 2
This trial aims to determine the most effective dose of onvansertib and evaluate its safety and effectiveness when combined with certain chemotherapy regimens in patients with a specific type of colorectal cancer that has
Image of The Oncology Institute of Hope and Innovation in Glendale, United States.

RO7198457

Cancer Vaccine

Recruiting1 awardPhase 2
This trial compares the efficacy of RO7198457 to watchful waiting in patients with ctDNA positive, resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon cancer.
Image of University of California Davis Comprehensive Cancer Center in Sacramento, United States.

Chemotherapy

Recruiting2 awardsPhase 3
This trial compares using intense local treatment to the usual approach of using only intravenous and/or oral medications to treat colorectal cancer spread to up to 4 sites.
Image of Exelixis Clinical Site #53 in Gilbert, United States.

Cabozantinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing the safety and effectiveness of a new cancer drug when used in combination with another cancer drug. The new drug is being tested on people with different types of cancer, including bladder, kidney, prostate, and breast cancer.
Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

Capecitabine +4 More

Chemotherapy

Recruiting1 awardPhase 2 & 3
This trial tests how well ctDNA testing in the blood predicts treatment for patients with stage IIA colon cancer after surgery. ctDNA are circulating tumor cells that are shed by tumors into the blood. Finding ctDNA in the blood means that there is very likely some small amounts of cancer that remain after surgery. However, this cancer, if detected, cannot be found on other tests usually used to find cancer, as it is too small. Testing for ctDNA levels may help identify patients with colon cancer after surgery who do benefit, and those who do not benefit, from receiving chemotherapy.

Popular filter options for colorectal-cancer cincinnati trials

Phase 3 Clinical Trials

View 71 phase 3 medical studies.

Clinical Trials With No Placebo

View 71 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.